Bronchoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Bronchoscopes Pipeline Market Report Overview

Bronchoscopes are minimally invasive diagnostic medical devices used to examine the trachea and proximal bronchi. These are introduced at the nose or mouth to observe distal branches of the bronchi. Under this category, only the equipment is tracked and not accessories associated with bronchoscopes.

The Bronchoscopes pipeline market research report provides comprehensive information about the Bronchoscopes pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Video Bronchoscopes

·        Flexible Video Bronchoscopes

·        Rigid Bronchoscopes

Key Territories ·        The US

·        Global

·        Europe

·        China

·        Israel

·        Australia

Key Regulatory Paths ·        510(k)

·        CE

·        NMPA

·        TGA

Leading Companies ·        Ambu A/S

·        Auris Health Inc

·        Boston Scientific Corp

·        Changzhou Lunghealth Medical Instrument Co Ltd

·        Huizhou Xzing Technology Co Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Bronchoscopes Pipeline Market by Segments

The key segments in the Bronchoscopes pipeline market are Video Bronchoscopes, Flexible Video Bronchoscopes, and Rigid Bronchoscopes. As of October 2023, Video Bronchoscopes have the most pipeline products.

Bronchoscopes Pipeline Market Analysis by Segments, 2023 (%)

Bronchoscopes Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Bronchoscopes Pipeline Market

Download a Free Report Sample

Bronchoscopes Pipeline Market Segmentation by Territories

Some of the key territories in the Bronchoscopes market are the US, Global, Europe, China, Israel, and Australia. As of October 2023, the US and global segment has the highest number of pipeline products.

Bronchoscopes Pipeline Market Analysis by Territories, 2023 (%)

Bronchoscopes Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Bronchoscopes Pipeline Market

Download a Free Report Sample

Bronchoscopes Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Bronchoscopes pipeline market are 510(k), CE, NMPA, and TGA. As of October 2023, 510(k) is the most followed pathway for pipeline products in the market.

Bronchoscopes Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Bronchoscopes Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Bronchoscopes Pipeline Market

Download a Free Report Sample

Bronchoscopes Pipeline Market – Competitive Landscape

Some of the key companies in the Bronchoscopes pipeline market are:

  • Ambu A/S
  • Auris Health Inc
  • Boston Scientific Corp
  • Changzhou Lunghealth Medical Instrument Co Ltd
  • Huizhou Xzing Technology Co Ltd

Ambu A/S (Ambu): It is a medical device company that manufactures and markets life-supporting devices. It focuses on single-use devices for anesthesia, endoscopy, cardiology, patient monitoring and diagnostics, and emergency care. It serves hospitals, clinics, sleep laboratories, and rescue services. The company’s product portfolio includes ventilation products for artificial respiration, resuscitators, single-use video scopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through a direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe, and Asia-Pacific. It has production facilities in China, Malaysia, and the US. Ambu is headquartered in Ballerup, Denmark.

Bronchoscopes Pipeline Market Analysis by Companies, 2023

Bronchoscopes Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Bronchoscopes Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Bronchoscopes Pipeline Market Segments Outlook

  • Video Bronchoscopes
  • Flexible Video Bronchoscopes
  • Rigid Bronchoscopes

Bronchoscopes Pipeline Market Territories Outlook

  • The US
  • Global
  • Europe
  • China
  • Israel
  • Australia

Bronchoscopes Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the Bronchoscopes under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Bronchoscopes under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Ambu A/S
Auris Health Inc
Boston Scientific Corp
Changzhou Lunghealth Medical Instrument Co Ltd
Huizhou Xzing Technology Co Ltd
Image In
Massachusetts General Hospital
Mauna Kea Technologies SAS
Noah Medical Corp
Polytechnic University of Catalonia
Pulmera Inc
Scivita Medical Technology Co Ltd
Tomophase Inc
UNandUP LLC
University of Oxford
University of Utah
Vanderbilt University
Z Square Ltd

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Bronchoscopes Overview

  • 3 Products under Development

    • 3.1 Bronchoscopes – Pipeline Products by Stage of Development
    • 3.2 Bronchoscopes – Pipeline Products by Segment
    • 3.3 Bronchoscopes – Pipeline Products by Territory
    • 3.4 Bronchoscopes – Pipeline Products by Regulatory Path
    • 3.5 Bronchoscopes – Pipeline Products by Estimated Approval Date
    • 3.6 Bronchoscopes – Ongoing Clinical Trials

  • 4 Bronchoscopes – Pipeline Products under Development by Companies

    • 4.1 Bronchoscopes Companies – Pipeline Products by Stage of Development
    • 4.2 Bronchoscopes – Pipeline Products by Stage of Development

  • 5 Bronchoscopes Companies and Product Overview

    • 5.1 Ambu A/S Company Overview

      • 5.1.1 Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Auris Health Inc Company Overview

      • 5.2.1 Auris Health Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Boston Scientific Corp Company Overview

      • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Changzhou Lunghealth Medical Instrument Co Ltd Company Overview

      • 5.4.1 Changzhou Lunghealth Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Huizhou Xzing Technology Co Ltd Company Overview

      • 5.5.1 Huizhou Xzing Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Image In Company Overview

      • 5.6.1 Image In Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Massachusetts General Hospital Company Overview

      • 5.7.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Mauna Kea Technologies SAS Company Overview

      • 5.8.1 Mauna Kea Technologies SAS Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Noah Medical Corp Company Overview

      • 5.9.1 Noah Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Polytechnic University of Catalonia Company Overview

      • 5.10.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Pulmera Inc Company Overview

      • 5.11.1 Pulmera Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Scivita Medical Technology Co Ltd Company Overview

      • 5.12.1 Scivita Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Tomophase Inc Company Overview

      • 5.13.1 Tomophase Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 UNandUP LLC Company Overview

      • 5.14.1 UNandUP LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 University of Oxford Company Overview

      • 5.15.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 University of Utah Company Overview

      • 5.16.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Vanderbilt University Company Overview

      • 5.17.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Z Square Ltd Company Overview

      • 5.18.1 Z Square Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Bronchoscopes- Recent Developments

    • 6.1 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • 6.2 Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer
    • 6.3 Aug 30, 2023: Broncus Medical Announces Interim Results for 2023
    • 6.4 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • 6.5 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • 6.6 May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023
    • 6.7 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • 6.8 Apr 20, 2023: Noah Medical secures $150m for next-generation robotic solutions
    • 6.9 Apr 12, 2023: Medtronic has a layoff in California
    • 6.10 Mar 29, 2023: Lucius partners portfolio company AerWave Medical, announces it has filed two new patent applications
    • 6.11 Mar 29, 2023: Broncus Medical Announces Annual Results for 2022
    • 6.12 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • 6.13 Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023
    • 6.14 Jan 13, 2023: Olympus says fixing issues raised by U.S. FDA about facilities in Japan
    • 6.15 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.17 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.18 Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
    • 6.19 Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
    • 6.20 Oct 21, 2022: Olympus Announces Leadership Succession Plan
    • 6.21 Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Bronchoscopes – Pipeline Products by Stage of Development 9

Bronchoscopes – Pipeline Products by Segment 10

Bronchoscopes – Pipeline Products by Territory 11

Bronchoscopes – Pipeline Products by Regulatory Path 12

Bronchoscopes – Pipeline Products by Estimated Approval Date 13

Bronchoscopes – Ongoing Clinical Trials 14

Bronchoscopes Companies – Pipeline Products by Stage of Development 15

Bronchoscopes – Pipeline Products by Stage of Development 16

Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview 17

aScope 5 – Selected Procedures – Product Status 17

aScope 5 – Selected Procedures – Product Description 17

aScope 5 – Smaller Patients – Product Status 18

aScope 5 – Smaller Patients – Product Description 18

Auris Health Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Integrated Bronchoscope – Product Status 19

Integrated Bronchoscope – Product Description 19

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20

EXALT Model Bx – Product Status 20

EXALT Model Bx – Product Description 20

Changzhou Lunghealth Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

Bronchoscope Navigation Control System and Catheter – Product Status 21

Bronchoscope Navigation Control System and Catheter – Product Description 21

Changzhou Lunghealth Medical Instrument Co Ltd – Ongoing Clinical Trials Overview 22

Bronchoscope Navigation Control System and Catheter – The Clinical Trial to Evaluate Efficacy and Safety of Bronchoscope Navigation Control System and Catheter with Prospective, Multicenter, Single Group Target Value Method for the Localized Biopsy of Peripheral Pulmonary Nodules 23

Huizhou Xzing Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Endofresh Bronchoscope – Product Status 24

Endofresh Bronchoscope – Product Description 24

Image In Pipeline Products & Ongoing Clinical Trials Overview 25

Disposable Bronchoscope – Product Status 25

Disposable Bronchoscope – Product Description 25

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 26

Optical Bronchoscopy Tool – Product Status 26

Optical Bronchoscopy Tool – Product Description 26

Mauna Kea Technologies SAS Pipeline Products & Ongoing Clinical Trials Overview 27

Cellvizio – COVID-19 – Product Status 27

Cellvizio – COVID-19 – Product Description 27

Cellvizio – Food Allergy – Product Status 28

Cellvizio – Food Allergy – Product Description 28

Noah Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 29

Galaxy System – Product Status 29

Galaxy System – Product Description 29

Noah Medical Corp – Ongoing Clinical Trials Overview 30

Galaxy System – Confirmation of Accuracy of the Tool-in-lesion Technology (TiLT) of the Galaxy System with Integrated TOMO Technology in Human Subjects to Bronchoscopically Biopsy Small Peripheral Pulmonary Nodules: TiLT Study 31

Galaxy System – First Human Use of a New Robotic Electromagnetic Navigation Bronchoscopy with Integrated Tool-In-Lesion-Tomosynthesis (TiLT) Technology (Galaxy System) for Small Peripheral Pulmonary Nodules 31

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 32

Virtual Bronchoscopy System – Product Status 32

Virtual Bronchoscopy System – Product Description 32

Pulmera Inc Pipeline Products & Ongoing Clinical Trials Overview 33

PathFinder – Product Status 33

PathFinder – Product Description 33

Scivita Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Broncho Videoscope System – Product Status 34

Broncho Videoscope System – Product Description 34

Tomophase Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Tomophase OCTIS Imaging system – Asthma – Product Status 35

Tomophase OCTIS Imaging system – Asthma – Product Description 35

Tomophase OCTIS Imaging system – Lung Cancer – Product Status 36

Tomophase OCTIS Imaging system – Lung Cancer – Product Description 36

Tomophase OCTIS Imaging system – Pulmonary Fibrosis – Product Status 36

Tomophase OCTIS Imaging system – Pulmonary Fibrosis – Product Description 37

UNandUP LLC Pipeline Products & Ongoing Clinical Trials Overview 38

Magnetic Bronchoscope – Product Status 38

Magnetic Bronchoscope – Product Description 38

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 39

Laser Bronchoscope – Product Status 39

Laser Bronchoscope – Product Description 39

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 40

Bimanual Operative Bronchoscope – Product Status 40

Bimanual Operative Bronchoscope – Product Description 40

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 41

Transoral Lung Access Device – Product Status 41

Transoral Lung Access Device – Product Description 41

Z Square Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

MultiPly HD – Product Status 42

MultiPly HD – Product Description 42

Glossary 63

Figures

Bronchoscopes – Pipeline Products by Stage of Development 9

Bronchoscopes – Pipeline Products by Segment 10

Bronchoscopes – Pipeline Products by Territory 11

Bronchoscopes – Pipeline Products by Regulatory Path 12

Bronchoscopes – Pipeline Products by Estimated Approval Date 13

Bronchoscopes – Ongoing Clinical Trials 14

Frequently asked questions

Bronchoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Bronchoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bronchoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Bronchoscopes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.